午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

Firmenname:
Telefon:-
E-Mail:sangon@qq.com
Nationalit?t:CHINA
URL: www.sangon.com
Produkte insgesamt:47239
214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318

Produktkatalog

5-ETHYL-4,5,6,7-TETRAHYDRO-THIAZOLO[5,4-C]PYRIDIN-2-YLAMINE, 10 mM in DMSO17899-49-9C8H13N3S
NVP-TAE 684, 10 mM in DMSO761439-42-3C30H40ClN7O3S
5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile (2R,3R)-2,3-dihydroxybutanedioate, 10 mM in DMS239463-85-5C26H31N3O8
Taladegib1258861-20-9C26H24F4N6O
TAK-901934541-31-8C28H32N4O3S
(S)-2-((R)-3-(4-chlorophenyl)-N’-((4-chlorophenyl)sulfonyl)-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamido)-3-methylbutanamide,1404117-65-2C27H27Cl2N5O3S
Tanzisertib, 10 mM in DMSO899805-25-5C21H23F3N6O2
TAK-071, 10 mM in DMSO1820812-16-5C24H24FN3O3
Subasumstat, 10 mM in DMSO1858276-04-6C25H28ClN5O5S2
Thalidomide-NH-C2-PEG3-OH2140807-23-2C21H27N3O8
Acetic acid, 2-[4-[(2-ethyl-3-benzofuranyl)carbonyl]phenoxy]-, 10 mM in DMSO91627-33-7C19H16O5
GR103545, 10 mM in DMSO126766-43-6C23H29Cl2N3O7
Tarloxotinib bromide, 10 mM in DMSO1636180-98-7C24H24Br2ClN9O3
Takeda103A, 10 mM in DMSO865609-72-9C24H23F2N7O
8-[(2,6-dimethylbenzyl)amino]-2,3-dimethylimidazo[1,2-a]pyridine-6-carboxylic acid816450-73-4C19H21N3O2
GP130 receptor agonist-1, 10 mM in DMSO339303-87-6C15H11FN2S
TAK-615, 10 mM in DMSO1664335-55-0C25H22FNO4
TAK-020, 10 mM in DMSO1627603-21-7C18H17N5O3
Tafetinib1032265-57-8C24H29FN4O2
gamma-preprotachykinin amide (72-92) acetate
3-(7,7-dimethyl-5-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyridin-2-yl)-1H-indole-7-carbonitrile, 10 mM in DMSO2759137-87-4C18H14N4O
ethyl 1-[(4-cyanobenzyl)oxy]-2-(3-cyanophenyl)-4-methyl-1H-imidazole-5-carboxylate, 10 mM in DMSO2738381-94-5C22H18N4O3
(3Z)-1-methyl-3-[2-(4-methylphenyl)-2-oxo-ethylidene]piperazin-2-one, 10 mM in DMSO178408-16-7C14H16N2O2
(D-Trp12,Tyr34)-pTH (7-34) amide (bovine) acetate
5-(3-bromo-4,5-dihydroisoxazol-5-yl)-3-(4-(tert-butyl)phenyl)-1,2,4-oxadiazole, 10 mM in DMSO2863687-18-5
TA-03, 10 mM in DMSO5778-80-3C14H16N2O
NVP-TAE 226, 10 mM in DMSO761437-28-9C23H25ClN6O3
Targocil, 10 mM in DMSO1200443-21-5C21H22ClN5O4S
TAK-243, 10 mM in DMSO1450833-55-2C19H20F3N5O5S2
5-bromo-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione26166-92-7C13H9BrN2O4
LY34051052326428-25-3C26H39N7O3
GPR34 receptor antagonist 2, 10 mM in DMSO907952-06-1C31H26ClNO4
TAK-6531358751-06-0C19H23N3O3S
MAT2A inhibitor 4, 10 mM in DMSO1391934-91-0C16H15ClFN
N-((4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-bromoaniline, 10 mM in DMSO1352608-94-6C22H18BrN7
5-(5-Fluoro-2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic Acid, 10 mM in DMSO452105-33-8C16H13FN2O3
TAK-733, 10 mM in DMSO1035555-63-5C17H15F2IN4O4
4-[(E)-{[4,6-Di(4-morpholinyl)-1,3,5-triazin-2-yl]hydrazono}methy l]-2,6-dimethoxyphenol, 10 mM in DMSO321557-16-8C20H27N7O5
5-Pyrimidinecarboxamide, 2-[[(1R,2S)-2-aminocyclohexyl]amino]-4-[[3-(2H-1,2,3-triazol-2-yl)phenyl]amino]-, rel-, 10 mM in DMSO1194954-52-3C19H23N9O
Taltirelin acetate, 10 mM in DMSO1549593-23-8C19H27N7O7
Talabostat mesylate, 10 mM in DMSO150080-09-4C10H23BN2O6S
Fasiglifam, 10 mM in DMSO1000413-72-8C29H32O7S
4-(6,7-dimethoxyquinolin-4-yl)oxyaniline, 10 mM in DMSO190728-25-7C17H16N2O3
TAK-593, 10 mM in DMSO1005780-62-0C23H23N7O3
TAK-632, 10 mM in DMSO1228591-30-7C27H18F4N4O3S
Tanimilast1239278-59-1C30H30Cl2F2N2O8S
TA-01, 10 mM in DMSO1784751-18-3C20H12F3N3
Taminadenant, 10 mM in DMSO1337962-47-6C10H8BrN7
4-QUinolinecarboxamide, N-[3-[[[2-[4-(aminosulfonyl)phenyl]ethyl]amino]carbonyl]phenyl]-1,2-dihydro-2-oxo-, 10 mM in DMSO939760-13-1C25H22N4O5S
TAS0728, 10 mM in DMSO2088323-16-2C26H32N8O3
C/EBPα inducer 12374285-52-4C20H12FN3O4
SCR130, 10 mM in DMSO2377858-38-1C19H13Cl2N3O2S
AG-270, 10 mM in DMSO2201056-66-6C30H27N5O2
Piperazine, 1-(4-fluorophenyl)-4-[(3,4,5-trimethoxyphenyl)methyl]-, 10 mM in DMSO80305-11-9C20H25FN2O3
Pomalidomide-PEG3-OH2140807-36-7C19H23N3O7
2-(2,6-dioxopiperidin-3-yl)-4-((9-hydroxynonyl)oxy)isoindoline-1,3-dione2619511-72-5C22H28N2O6
Talampanel, 10 mM in DMSO161832-65-1C19H19N3O3
(1S,4R)-N-Desmethyl Sertraline Hydrochloride, 10 mM in DMSO675126-07-5C16H16Cl3N
Fosravuconazole L-lysine ethanolate914361-45-8C31H40F2N7O8PS
TAK-960, 10 mM in DMSO1137868-52-0C27H34F3N7O3
Takeda-6d, 10 mM in DMSO1125632-93-0C27H19ClFN5O3S
Targapremir-2101049722-30-6C32H36N10O2
Balipodect, 10 mM in DMSO1238697-26-1C23H17FN6O2
TAI-1, 10 mM in DMSO1334921-03-7C24H21N3O3S
Dazonone, 10 mM in DMSO105622-85-3C11H10ClN3O
TAK-659 hydrochloride1952251-28-3C17H22ClFN6O
N-Cyclohexyl-4-[1-(1-piperazinyl)-2,6-naphthyridin-3-yl]-2-pyridinamine1071135-06-2C23H28N6
TAK-715, 10 mM in DMSO303162-79-0C24H21N3OS
TAK-418, 10 mM in DMSO1818252-53-7
NSC 73150, 10 mM in DMSO66680-03-3C12H12N4O2
Talnetant, 10 mM in DMSO174636-32-9C25H22N2O2
TAK-779, 10 mM in DMSO229005-80-5C33H39N2O2.Cl
N,N,O-Tridesmethylvenlafaxine, 10 mM in DMSO149289-29-2C14H21NO2
TAK-285, 10 mM in DMSO871026-44-7C26H25ClF3N5O3
Taprenepag, 10 mM in DMSO752187-80-7C24H22N4O5S
TAK-4411186231-83-3C28H31F3N4O6
T-900607, 10 mM in DMSO261944-52-9C14H10F5N3O4S
TAO Kinase inhibitor 1, 10 mM in DMSO850467-66-2C25H24N2O2
N-(3-cyano-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)pyrazine-2-carboxamide, 10 mM in DMSO312508-42-2C14H12N4OS
TAK-041, 10 mM in DMSO1929519-13-0C18H15F3N4O3
TAM-IN-22135642-56-5C31H27F2N7O3
Exo-1, 10 mM in DMSO461681-88-9C15H12FNO3
Thalidomide-PEG4-Propargyl2098799-77-8C24H28N2O9
Benzonitrile, 3,3''-[(2-oxo-1,3-cyclohexanediylidene)dimethylidyne]bis- (9CI), 10 mM in DMSO63476-70-0C22H16N2O
EAAT2 activator 1, 10 mM in DMSO892415-28-0C16H11ClFN3S
(E)-3-(3,4-dichlorophenyl)-N-(2-(4-(methylsulfonyl)piperazin-1-yl)-2-oxoethyl)acrylamide, 10 mM in DMSO2505001-62-5C16H19Cl2N3O4S
2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethyl methanesulfonate, 10 mM in DMSO160969-03-9C11H13F3O5S
KCNQ2/3 activator-1, 10 mM in DMSO1009344-33-5C23H29FN2O
TA-02, 10 mM in DMSO1784751-19-4C20H13F2N3
Takinib, 10 mM in DMSO1111556-37-6C18H18N4O2
1-(2,3-DIHYDRO-BENZO[1,4]DIOXIN-6-YL)-5-OXO-PYRROLIDINE-3-CARBOXYLIC ACID, 10 mM in DMSO260555-42-8C13H13NO5
Tabernanthalog, 10 mM in DMSO2483829-58-7C14H18N2O
Pomalidomide-PEG2-OH2143097-10-1C17H19N3O6
Thalidomide-NH-PEG1-NH2 hydrochloride2154342-56-8C17H21ClN4O5
2H-Imidazo[4,5-b]pyrazin-2-one, 1,3-dihydro-6-[6-(1-hydroxy-1-methylethyl)-3-pyridinyl]-1-[(tetrahydro-2H-pyran-4-yl)methyl]-, 10 mM1021917-65-6C19H23N5O3
Cyclopenta[c][1]benzopyran-8-ol, 1,2,3,3a,4,9b-hexahydro-4-(4-hydroxyphenyl)-, (3aR,4S,9bS)-rel-, 10 mM in DMSO533883-77-1C18H18O3
3-(9-Chloro-3-methyl-4-oxoisoxazolo[4,3-c]quinolin-5(4H)-yl)-N-(3,4,5-trimethoxyphenyl)benzeneacetamide, 10 mM in DMSO246238-55-1C28H24ClN3O6
TAE-11414469-59-2C39H51I3N6O9
Taprizosin210538-44-6C25H26N6O4S
2-(2,6-dioxopiperidin-3-yl)-4-((7-hydroxyheptyl)oxy)isoindoline-1,3-dione2093536-10-6C20H24N2O6
214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318
Copyright 2019 ? ChemicalBook. All rights reserved